Skip to main content

New 'Autism Toolkit' for Clinicians Launched


NEW ORLEANS — A new "autism toolkit" designed to help clinicians diagnose and manage autism spectrum disorders (ASD) and provide resources for the families of these children has been launched by the American Academy of Pediatrics (AAP).
Released here at the AAP 2012 National Conference and Exhibition, the second edition of the autism toolkit is entitled Autism: Caring for Children With Autism Spectrum Disorders: A Resource Toolkit for Clinicians and includes the latest AAP guidelines on autism screening, surveillance, diagnosis, treatment, and referral.
According to the toolkit coeditor Susan E. Levy, MD, University of Pennsylvania School of Medicine, Philadelphia, it provides doctors with tools to help them "be more comfortable in their understanding of the policies put forward by the AAP for evaluating and managing ASD."
"We modelled it after the toolkit for attention-deficit/hyperactivity disorder, which has had very good uptake by pediatricians. We were inspired by how effective that was, and we think the new toolkit is equally great," said Dr. Levy, who is board certified in pediatrics and neurodevelopmental disabilities
According to Susan L. Hyman, chair of the autism subcommittee of the AAP Council on Children With Disabilities, this second edition, the first since 2007, was revised on the basis of feedback from primary care providers for ease of use and includes additional and updated topic areas related to medical, behavioral, and educational care.
Dr. Levy emphasized that the toolkit was developed with abundant input.
"We were part of the group that wrote the first version, and we were tasked with the revision. It went out for review to members of the Council, and even more importantly, to families with different-aged children with ASD. The information was vetted through families," she said.
The toolkit includes more than 70 tools for healthcare providers, including developmental screening questionnaires and screening tools, diagnostic criteria, treatment algorithms, family handouts in English and Spanish, record-keeping tools, and clinician fact sheets on specific health concerns.
Its main components include the following:
  • Practice-focused guidelines and recommendations: New and recently reaffirmed AAP clinical reports and policy statements on ASD identification, evaluation, and management.
  • Developmental screening and surveillance tools: Algorithms, questionnaires, growth charts, diagnostic criteria, Centers for Disease Control and Prevention developmental milestones, and record-keeping tools.
  • Visit preparation and tracking aids: Detailed guidance for facilitating ASD office visits; tools to track key steps in identification, diagnosis, intervention, and management.
  • Clinician fact sheets: Expert insights and advice on Asperger syndrome, sleep disorders, toilet training, nutrition, gastrointestinal disorders, seizures and epilepsy, psychopharmacology, complementary and alternative therapies, transition to adult care, and more.
  • Referral tools and time-savers: Ready-to-use early-intervention referral and follow-up forms.
  • Coding and billing guidance: Techniques to help ensure prompt, proper payment for ASD-related services.
  • Family education handouts in English and Spanish: Handouts for quick duplication and distribution; topics include behavioral challenges, early-intervention services, school-based services, medications, vaccines, toilet training, sleep problems, sibling issues, eating problems, transition to adulthood, and more.
Dr. Levy added that one of the most valuable additions is guidance for the medical workup of children with autism.
"We worked with a geneticist, for example. The information is up-to-date," she said.
David Matthews, MD, of Jonesboro, Arkansas, who is president of the state AAP chapter, attended a presentation by Dr. Levy and commented on the toolkit's value.
"I think it will be a very good resource for dealing with patients. In my practice, only 2 of us are trained for upper-level autism screening, and this toolkit will be especially helpful to physicians with less frequent contact with these patients," he said.
Early Recognition Critical
Commenting on the findings for Medscape Medical News, Laura Politte, MD, a child and adolescent psychiatrist and clinical instructor at Harvard Medical School in Boston, Massachusetts, noted that the prevalence of ASD is growing, and so it is more critical than ever that clinicians become more familiar with how to recognize the early signs of the disorder and make appropriate specialist referrals.
"Early recognition by pediatricians is particularly imperative, as outcomes for children with ASD can improve substantially with intensive educational and behavioral therapies instituted early in the course of development," said Dr. Politte, who is also an assistant in psychiatry and pediatrics at Massachusetts General Hospital.
She noted that the toolkit "has the potential to improve early detection of ASD and the quality of care throughout childhood for those affected."
Dr. Levy, Dr. Hyman, Dr. Matthews, and Dr. Politte have disclosed no relevant financial relationships.
American Academy of Pediatrics (AAP) 2012 National Conference and Exhibition. Presented October 20, 2012.

Comments

Post a Comment

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...
Post a Comment
Read more

FDA Decision Delayed for Truvada in HIV PrEP

June 11, 2012 — The US Food and Drug Administration (FDA) has delayed its decision on allowing the use of tenofovir disoproxil fumarate/emtricitabine ( Truvada , Gilead) as preexposure prophylaxis (PrEP) so that the proposed risk evaluation and mitigation strategy (REMS) can be reviewed. In early May, the FDA's Antiviral Drugs Advisory Committee  strongly backed  approval of the first-ever drug for the prevention of sexually acquired HIV-1 infection. However, concerns by the panel at the time included that people may neglect condom use if they feel they are protected by PrEP. Panelists were also concerned that uninfected people taking PrEP who become infected with HIV may not switch to a 3-drug regimen as recommended. According to the company, the FDA has postponed the target date to September 14 so it can review Gilead's REMS plan to help ensure that patients will not misuse the drug. The committee's recommendation for supplemental approval of tenofovir/emtricit...
Post a Comment
Read more

Antidepressants Linked to Higher Diabetes Risk in Kids

Pediatric patients who use antidepressants may have an elevated risk for type 2 diabetes, the authors of a new study report. In a retrospective cohort study of more than 119,000 youths 5 to 20 years of age, the risk for incident type 2 diabetes was nearly twice as high among current users of certain types of antidepressants as among former users, Mehmet Burcu, PhD, and colleagues report in an article  published online October 16 in  JAMA Pediatrics . The risk intensified with increasing duration of use, greater cumulative doses, and higher daily doses of these antidepressants. The findings point to a growing need for closer monitoring of these products, including greater balancing of risks and benefits, in the pediatric population, the authors caution. They undertook the study because, despite growing evidence of an association between antidepressant use and an increased risk for type 2 diabetes in adults, similar research in pediatric patients was scarce. "To our know...
Post a Comment
Read more